Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$12,400,892
+$387,169 QoQ
Shares Held
96,505
-3.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#666
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. MRK ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
|
12,976 | $2,033,598 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,400,892 | 96,505 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $12,013,723 | 99,873 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $10,930,303 | 103,841 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,268,641 | 110,433 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $8,689,709 | 109,774 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $10,914,008 | 121,591 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $10,194,014 | 102,473 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $11,783,553 | 103,765 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $12,038,064 | 97,238 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $12,976,886 | 98,347 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $10,831,355 | 99,352 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $10,009,931 | 97,231 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,732,278 | 101,675 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,476,861 | 98,476 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,039,303 | 99,498 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,675,298 | 100,735 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,306,998 | 102,084 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,175,954 | 99,646 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,724,776 | 87,745 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $6,548,840 | 87,190 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,060,971 | 90,793 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,637,452 | 86,100 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,771,155 | 82,777 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,699,874 | 80,770 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,440,663 | 83,288 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,782,873 | 88,158 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||